Results 131 to 140 of about 659,276 (230)

Repurposing DPP-4 inhibitors as anticancer agents in KRAS-mutated pancreatic ductal adenocarcinoma. [PDF]

open access: yesBMC Pharmacol Toxicol
Ramalingam PS   +12 more
europepmc   +1 more source

Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial. [PDF]

open access: yesBMC Med
Barchetta I   +18 more
europepmc   +1 more source

The mechanism study of targeting DPP4 in regulating ferroptosis and its influence on endometrial receptivity in PCOS. [PDF]

open access: yesBiol Sex Differ
Zhang J   +9 more
europepmc   +1 more source

Medication Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). [PDF]

open access: yesDiabetes Care
Gonzalez JS   +15 more
europepmc   +1 more source

Therapeutic potential of targeting ceramide for early cardiometabolic lipotoxicity in vivo study. [PDF]

open access: yesSci Rep
Shalaby YM   +5 more
europepmc   +1 more source

Sitagliptin Phosphate: Development of a Dissolution Method for Coated Tablets Based on In Vivo Data for Improving Medium Sensitivity

open access: bronze, 2014
Alini Dall Cortivo Lange   +5 more
openalex   +1 more source

MicroRNAs modulated by DPP-4 inhibitor and bedtime NPH insulin therapy in individuals with type 2 diabetes. [PDF]

open access: yesFront Endocrinol (Lausanne)
Santos AS   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy